These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 12180304

  • 1. [Hepatitis C: therapeutic perspectives].
    Trépo C.
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B297-302. PubMed ID: 12180304
    [No Abstract] [Full Text] [Related]

  • 2. [Hepatitis C is curable. Even slightly elevated liver enzymes need further examination].
    Niederau C.
    MMW Fortschr Med; 2008 Mar 27; 150(13):26. PubMed ID: 18522352
    [No Abstract] [Full Text] [Related]

  • 3. [Chronic hepatitis C. A new chance with Consensus Interferon for patients with handicaps].
    MMW Fortschr Med; 2002 Nov 07; 144(45):56-7. PubMed ID: 12534066
    [No Abstract] [Full Text] [Related]

  • 4. [Treatment of patients with chronic hepatitis C virus infection and normal transaminases].
    Serfaty L.
    Gastroenterol Clin Biol; 2002 Apr 07; 26 Spec No 2():B202-5. PubMed ID: 12180289
    [No Abstract] [Full Text] [Related]

  • 5. [Management of patients with hepatitis C virus infection. Virological tests].
    Pawlotsky JM.
    Gastroenterol Clin Biol; 2002 Apr 07; 26 Spec No 2():B180-7. PubMed ID: 12180286
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of patients with chronic hepatitis C who relapsed or did not respond to a previous treatment].
    Zoulim F.
    Gastroenterol Clin Biol; 2002 Apr 07; 26 Spec No 2():B225-30. PubMed ID: 12180293
    [No Abstract] [Full Text] [Related]

  • 7. [Evaluation of response to treatment in chronic hepatitis C].
    Leroy V, Hilleret MN.
    Gastroenterol Clin Biol; 2002 Apr 07; 26 Spec No 2():B23-31. PubMed ID: 12180294
    [No Abstract] [Full Text] [Related]

  • 8. The faster the better?
    Carulli N.
    Intern Emerg Med; 2006 Apr 07; 1(2):91-3. PubMed ID: 17111779
    [No Abstract] [Full Text] [Related]

  • 9. [Treatment of patients with chronic hepatitis C who have not been previously treated].
    Marcellin P, Boyer N.
    Gastroenterol Clin Biol; 2002 Apr 07; 26 Spec No 2():B194-201. PubMed ID: 12180288
    [No Abstract] [Full Text] [Related]

  • 10. [Treatment for chronic hepatitis C, more opportunity, more challenge].
    Wei L.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jul 07; 17(7):481-3. PubMed ID: 19912676
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ribavirin in chronic hepatitis C: past and future.
    Loustaud-Ratti V, Rousseau A, Marquet P, Denis F, Alain S.
    Expert Rev Anti Infect Ther; 2009 Apr 07; 7(3):249-53. PubMed ID: 19344238
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.
    Uyama H, Enomoto H, Kishima Y, Yamamoto M, Yoshida K, Okuda Y, Hirotani T, Kuroda T, Ito H, Matsuda M, Terabayashi M, Noguchi S, Kawase I, Nakamura H.
    Hepatogastroenterology; 2003 Apr 07; 50(54):2112-6. PubMed ID: 14696476
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.